Ishita Dhawan

Ishita Dhawan

Auto-generated profile, based on publicly available information

Ishita Dhawan

Department of Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2012 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
MWMarta P. Wolfshorndl
Marta P. Wolfshorndl
RBRachel Baskin
Rachel Baskin
IDIshita Dhawan
Ishita Dhawan
CLCasey Londergan
Casey Londergan

1 October 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
IDIshita Dhawan
Ishita Dhawan
BOBrendon O’cOnnell
Brendon O’cOnnell
APAmit Patel
Amit Patel
RSRon Schey
Ron Schey
HPHenry P. Parkman
Henry P. Parkman
FFFrank Friedenberg
Frank Friedenberg

1 May 2018 in Gastroenterology
Verified
Journal Article
Closed access
MSMohammed Saadi
Mohammed Saadi
AEAdam C. Ehrlich
Adam C. Ehrlich
MBMarina Baskharoun
Marina Baskharoun
IDIshita Dhawan
Ishita Dhawan
HPHenry P. Parkman
Henry P. Parkman
RSRon Schey
Ron Schey

1 January 2021 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
IDIshita Dhawan
Ishita Dhawan
SPSonali Palchaudhuri
Sonali Palchaudhuri
GGGregory G. Ginsberg
Gregory G. Ginsberg

1 October 2019 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
YKYii Chun Khiew
Yii Chun Khiew
IDIshita Dhawan
Ishita Dhawan
MMMitul B. Modi
Mitul B. Modi
SBSiddharth Bhattacharyya
Siddharth Bhattacharyya
FNFrederick A. Nunes
Frederick A. Nunes
INTRODUCTION: Current colorectal cancer (CRC) screening guidelines are directed at early detection of adenocarcinoma via stool testing or direct endoscopic or radiologic visualization. Compared to a colonoscopy, fecal immunochemical Testing (FIT), a non-invasive test that detects hemoglobin in stool by immunoassay, has similar CRC detection rates. We report a case of mantle cell lymphoma (MCL) involving the gastrointestinal tract (GIT) in a patient diagnosed through routine CRC screening. CASE DESCRIPTION/METHODS: A 70 year-old male with a history of diverticulitis was referred for urgent colonoscopy following a positive FIT. He reported a seven-month history of right upper quadrant abdominal pain, pruritus, and a 19 pound unintentional weight loss. He denied fever, night sweats, melena, hematochezia, and family history of malignancy. Physical exam did not reveal splenomegaly and lymphadenopathy. Notable labs included normocytic anemia and a normal LDH. Colonoscopy showed congested, nodular and thickened mucosal folds in the terminal ileum, ascending colon, and cecum. Random biopsies revealed diffuse atypical lymphoid infiltrates in a multiple lymphomatous polyposis pattern with cyclin D1, CD5 and CD20 immunohistochemical positivity consistent with MCL. PET-CT detected bone marrow and diffuse lymph node involvement. He tolerated six cycles of lymphoma-directed chemotherapy with complete metabolic response on imaging. DISCUSSION: Extranodal disease at primary presentation accounts for 25% of patients with MCL. Microscopic gastrointestinal involvement in MCL at presentation is widely underestimated and has been documented in up to 80% of cases at the time of diagnosis, suggesting that MCL has a propensity to home to the GIT. Clinically, most patients with MCL with GIT involvement are asymptomatic, but can also present with abdominal pain, altered bowel habits, and gastrointestinal bleeding. To date, annual FIT testing has been used solely as a screening test for CRC. The role of non-invasive stool testing such as FIT, and its detection of other primary malignancies involving the gastrointestinal tract besides CRC, has not been studied and requires further investigation.

1 October 2016 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
IDI. Dhawan
I. Dhawan
TLT. Li
T. Li
CFC. Fundakowski
C. Fundakowski
MLM. Lango
M. Lango
JRJ.A. Ridge
J.A. Ridge
TGT.J. Galloway
T.J. Galloway